Discuss these with your doctor: Diet and exercise: If weight loss could reduce your back pain, ask about safe exercises and dietary recommendations that pair well with semaglutide
The FDA has approved Eli Lilly and Companys Foundayo, a GLP-1 weight loss pill that removes one of the biggest barriers in treatmentcomplex dosing
Trials.lilly.com listed TRIUMPH-7 (chronic low back pain), TRIUMPH-8 (general obesity), and TRIUMPH-9 (obesity without type 2 diabetes) as actively enrolling as of April 2026, bringing the total program well above eight trials
Boosts Energy, Mood, & Focus By activating GLP-1 receptors in the brain and body, microdosing may promote mental clarity, energy balance, and overall vitality
Glucagon like peptide-1 receptor agonists for the management of obesity and non-Alcoholic fatty liver disease: a novel therapeutic option
they continuously evaluate new research to ensure patients receive guidance grounded in the latest evidence